Table 3 Multivariate conditional logistic regression analysis of variables associated with occurrence of thrombocytopenia
From: Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
| OR (95%CI) | P-value | |
|---|---|---|
| Male | 1.25 (0.52–3.01) | 0.62 |
| Body mass index (kg/m2) (per 1-kg/m2 increment) | 0.93 (0.72–1.08) | 0.25 |
| CLCRC-G ≤ 60 mL/min | 2.90 (1.13–7.44) | 0.027 |
| Hemoglobin concentration (g/dL) (per 1-g/dL increment) | 0.89 (0.72–1.08) | 0.23 |
| Platelet count (×103/μL) (per 1.0 × 103/μL increment) | 0.993 (0.989–0.997) | 0.0002 |
| Bacteraemia | 1.44 (0.51–4.01) | 0.49 |
| Duration of linezolid treatment (days) (per 1-day increment) | 1.010 (0.989–1.031) | 0.36 |